Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Carbapenemase-Producing Organism (CPO) and Vancomycin-Resistant Enterococcus (VRE) Management With BD Solutions

NCT05200546 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05200546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Carbapenemase-Producing Organism (CPO) and Vancomycin-Resistant Enterococcus (VRE) Management With BD Solutions
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
February 18, 2022
Completion date
March 31, 2023
Enrollment
3,921 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug-resistant bacteria screening